BAC
Bank of America Corporation
BAC has slightly lower modeled downside risk, despite its lower overall score.
FCNCA
First Citizens BancShares, Inc.
FCNCA has a slight edge over BAC overall on the model score.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
FCNCA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
FCNCA's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like FCNCA.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over FCNCA in the historical PE scenario, which offers more potential upside but is not a forecast.
FCNCA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.5x | $1,649 | -29% |
| Forward | 11x | $2,318 | — |
| Fair | 12x | $2,274 | -1.9% |
| Current | 12x | $2,318 | — |
| Expensive | 14x | $2,794 | +21% |
Historical ranges are pointers, not guarantees.
FCNCA's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 11x next year's earnings.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
FCNCA Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for FCNCA, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over FCNCA on earnings, with more consistent year-over-year improvement.
FCNCA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $208.95 | +7.3% |
| Q3 2026 | $194.71 | +15% |
| Q2 2026 | $186.56 | +10% |
| Q1 2026 | $173.40 | -0.7% |
| Q4 2025 | $165.24 | -13% |
| Q3 2025 | $169.10 | -3.1% |
| Q2 2025 | $169.44 | -6.8% |
| Q1 2025 | $174.62 | -3.1% |
| Q4 2024 | $189.41 | -76% |
FCNCA's earnings per share have fallen from their peak: $194.71 over the past year, against $784.51 in late 2023.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over FCNCA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
FCNCA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.4B | 0% |
| Q2 2026 | $2.4B | +2.5% |
| Q1 2026 | $2.3B | +0.7% |
| Q4 2025 | $2.4B | +1.2% |
| Q3 2025 | $2.4B | -0.5% |
| Q2 2025 | $2.4B | -3.5% |
| Q1 2025 | $2.3B | -6% |
| Q4 2024 | $2.4B | -1.9% |
FCNCA's revenue fell from its 2023 peak and has held roughly level since: $2.4B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 33% | +2.2 points |
| Q2 2026 | 37% | +4.7 points |
| Q1 2026 | 30% | +2.2 points |
| Q4 2025 | 33% | +2.7 points |
| Q3 2025 | 31% | -4.8 points |
| Q2 2025 | 32% | -7.9 points |
| Q1 2025 | 28% | -13 points |
| Q4 2024 | 31% | +1.5 points |
FCNCA has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
FCNCA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $689M | +1.6% |
| Q2 2026 | $941M | +28% |
| Q1 2026 | $31M | +$36M |
| Q4 2025 | $807M | -19% |
| Q3 2025 | $678M | -23% |
| Q2 2025 | $733M | +132% |
| Q1 2025 | -$5M | -101% |
| Q4 2024 | $991M | +43% |
FCNCA has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has 7.2B diluted shares, down 5.3% from a year ago, with $25.6B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
FCNCA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.5% | -285K shares |
| 1 year | -12% | -1.6M shares |
| 3 years | -23% | -3.3M shares |
| 5 years | +15% | +1.4M shares |
| Available history | +1% | +109K shares |
FCNCA has the edge over BAC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $600M |
| Q2 2026 | $606M |
| Q1 2026 | $899M |
| Q4 2025 | $900M |
| Q3 2025 | $896M |
| Q2 2025 | $613M |
| Q1 2025 | $618M |
| Q4 2024 | $948M |
FCNCA spent $3B buying back its own shares over the past year, down 2.3% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
FCNCA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.1x | High |
| Q2 2026 | 8.3x | High |
| Q1 2026 | 9.4x | High |
| Q4 2025 | 10.4x | High |
| Q3 2025 | 11.6x | High |
| Q2 2025 | 11.1x | High |
| Q1 2025 | 10.8x | High |
| Q4 2024 | 9.7x | High |
FCNCA has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
FCNCA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.7 | Neutral |
| Stochastic | 72.5 | Neutral |
FCNCA's weekly RSI is 62 (neutral) and its Stochastic is 73 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
FCNCA PE vs Financial Services Sector
| Metric | FCNCA | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 8.6% below |
| PE % | 54 | 63 | 9 pts below |
FCNCA has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
FCNCA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2,209.5 | 4.9% above |
| 20 week MA | $2,185.1 | 6.1% above |
| 50 week MA | $2,081.5 | 11% above |
| 100 week MA | $2,003.1 | 16% above |
| 200 week MA | $1,746.4 | 33% above |
FCNCA has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
FCNCA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $530.5 | $593.1 | +12% |
| 2021 | $593.1 | $864.4 | +46% |
| 2022 | $864.4 | $751.1 | -13% |
| 2023 | $751.1 | $1,419.0 | +89% |
| 2024 | $1,419.0 | $2,132.4 | +50% |
| 2025 | $2,132.4 | $2,180.5 | +2.3% |
| 2026 YTD | $2,180.5 | $2,317.9 | +6.3% |
FCNCA has the edge over BAC on returns for 2026, with the stronger performance.